Updated August 22, 2013
The nationwide shortage of the TB drug isoniazid (INH) appears to be resolving. Effective September 1, 2013, MDH will return to previous procedures for supplying INH for the treatment of latent TB infection (LTBI). Please follow the standard recommendations and procedures described under Medication for latent TB infection.
Thank you for your patience and flexibility during this challenging time.